IN8bio, Inc. Files 8-K on Shareholder Vote Matters
Ticker: INAB · Form: 8-K · Filed: May 9, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
IN8bio filed an 8-K about shareholder votes. Standard corporate stuff.
AI Summary
IN8bio, Inc. filed an 8-K on May 9, 2025, reporting on matters submitted to a vote of security holders as of May 8, 2025. The filing details the company's corporate structure, including its incorporation in Delaware and its principal executive offices located at the Empire State Building in New York.
Why It Matters
This filing indicates that IN8bio, Inc. is engaging in corporate governance activities requiring shareholder approval, which is a standard but important procedural step for public companies.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding shareholder votes and does not appear to contain significant new financial or operational information.
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- May 8, 2025 (date) — Earliest event reported
- May 9, 2025 (date) — Date of Report
- Empire State Building (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of IN8bio, Inc.'s security holders?
The filing states that the 8-K is for 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 8, 2025.
What is IN8bio, Inc.'s state of incorporation?
IN8bio, Inc. is incorporated in Delaware.
Where are IN8bio, Inc.'s principal executive offices located?
IN8bio, Inc.'s principal executive offices are located at 350 5th Avenue, Suite 5330, New York, New York.
What is the SEC file number for IN8bio, Inc.?
The SEC file number for IN8bio, Inc. is 001-39692.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding IN8BIO, INC. (INAB).